The commercial real estate consulting firm Newmark came out with a ranking of best markets for life science real estate, paired together with market analyses for each market. The Triangle is ranked 4th out of 14 clusters with the following subscores:
The Triangle’s “market maturity” is low because of our relatively low amounts of venture capital funding. “Future growth” is low for us since it’s relative to Boston and San Francisco; they have a combined total of 47.5 million square feet of proposed life science-oriented developments, combined to just north of 9M sq.ft. down here.
The N&O took a deeper dive into the data, but you could also look at the report yourself since it’s not a very hard read: